Showing 35,225 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

PrEP programmes & uptake

Don’t Underestimate the Benefit of HIV PrEP for Trans Women

Editor's pick
POZ
22 September 2021
HIV treatment

Ritonavir Factsheet

About HIV
September 2021
Sex workers

Successful PrEP interventions in marginalised communities: the Ashodaya PrEP Project

News
22 September 2021

aidsmap news: One dose of TAF every three days gets more drug into cells than a daily dose of TDF, 21 September 2021

September 2021
Kidney problems

People over 50 years old or with existing kidney dysfunction are more likely to get kidney damage when using tenofovir disoproxil-based PrEP

News
21 September 2021
Coronavirus

Children dying of Covid-19 in South Africa often also have HIV

Editor's pick
Business Day
20 September 2021
PrEP programmes & uptake

US: States Late to Adopt PrEP Risk Falling Further Behind

Editor's pick
American Journal of Managed Care
20 September 2021
Men who have sex with men (MSM)

Conversion therapy thrives globally as bans gather pace

Editor's pick
Thomson Reuters Foundation
20 September 2021
New & experimental HIV treatments

Exavir Therapeutics announces publication of preclinical data for novel tenofovir prodrug, XVIR-210, in Nature Communications, demonstrating long-acting exposures sufficient for antiviral activity against HIV and HBV

Editor's pick
GlobeNewswire
20 September 2021
Access to healthcare

Unitaid at 15

Editor's pick
The Lancet (free registration required)
17 September 2021
Global health initiatives

Key Issues and Questions for PEPFAR’s Future

Editor's pick
Kaiser Family Foundation
17 September 2021
Cancer

How to Reduce Anal Cancers in People With HIV

Editor's pick
Infectious Disease Special Edition
17 September 2021
People & personal stories

Stop Asking Me to Protect You From My HIV

Editor's pick
TheBody
17 September 2021
Ethnic & cultural minorities

Realigned US HIV Panel Works to Rebuild Community Bridges

Editor's pick
Medscape (requires free registration)
17 September 2021
PrEP science

One dose of TAF every three days gets more drug into cells than a daily dose of TDF

News
17 September 2021
Access to healthcare

US: Most People Diagnosed With HIV Have Health Insurance and Are Receiving Care

Editor's pick
POZ
16 September 2021
Cancer

Combination Antiretroviral Therapy and CD4/CD8 Ratio on the Risk for Kaposi Sarcoma, Non-Hodgkin Lymphoma in Patients With HIV Infection

Editor's pick
Infectious Disease Advisor
16 September 2021
Hepatitis C treatment

Ultra-short course treatment for hepatitis C: high failure rate but does not compromise second-line treatment

News
16 September 2021

Best drug if starting treatment with a high viral load – HIV update, 15 September 2021

September 2021
Government, leadership & policy

HIV, Hepatitis C and Sexually Transmitted and Blood-Borne Infections in Canada: Top Election 2021 Issues

Editor's pick
HIV Legal Network
15 September 2021
Sexually transmitted infections tests & treatment

Keep Screening Women for Chlamydia and Gonorrhea, Says USPSTF

Editor's pick
MedPage Today
15 September 2021
Clinical trials

Thinking about joining a clinical trial?

About HIV
September 2021
HIV & criminal law

California May Outlaw Stealthing, the Removal of a Condom Without Consent

Editor's pick
POZ
14 September 2021
Government, leadership & policy

The U.N. has a plan to end AIDS by 2030. But Russia doesn’t like it.

Editor's pick
Washington Post
14 September 2021